{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:38:20Z","timestamp":1784907500069,"version":"3.55.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 A1070829"],"award-info":[{"award-number":["RO1 A1070829"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,15]]},"DOI":"10.1093\/cid\/cix446","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T08:21:57Z","timestamp":1496132517000},"page":"990-998","source":"Crossref","is-referenced-by-count":41,"title":["A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance Mechanisms"],"prefix":"10.1093","volume":"65","author":[{"given":"Max R","family":"Schroeder","sequence":"first","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine,"},{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T","family":"Chancey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine,"},{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Thomas","sequence":"additional","affiliation":[{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"},{"name":"Georgia Emerging Infections Program, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hsuan","family":"Kuo","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah W","family":"Satola","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine,"},{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"},{"name":"Georgia Emerging Infections Program, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M","family":"Farley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine,"},{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"},{"name":"Georgia Emerging Infections Program, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Stephens","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine,"},{"name":"Laboratories of Microbial Pathogenesis, Department of Veterans Affairs Medical Center,"},{"name":"Georgia Emerging Infections Program, and"},{"name":"Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"key\n\t\t\t\t20180306212528_CIT0001","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306212528_CIT0002","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment","volume":"365","author":"Stephens","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306212528_CIT0003","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1128\/AAC.00234-06","article-title":"Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae","volume":"50","author":"Bergman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/mdr.2014.0086","article-title":"Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States","volume":"21","author":"Hawkins","year":"2015","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20180306212528_CIT0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/321001","article-title":"Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae","volume":"184","author":"Gay","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0007","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/315853","article-title":"The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment","volume":"182","author":"Gay","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0008","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1128\/AAC.00319-13","article-title":"Molecular resistance mechanisms of macrolide-resistant invasive Streptococcus pneumoniae isolates from Alaska, 1986 to 2010","volume":"57","author":"Rudolph","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fmicb.2015.00026","article-title":"Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Chancey","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0010","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00598-07","article-title":"The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271","volume":"51","author":"Del Grosso","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0011","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","journal-title":"MMWR Recommendations and Reports"},{"key":"key\n\t\t\t\t20180306212528_CIT0012","doi-asserted-by":"crossref","first-page":"C43","DOI":"10.1016\/j.vaccine.2011.07.047","article-title":"The future of pneumococcal disease prevention","volume":"29","author":"Rodgers","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306212528_CIT0013","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2672.2010.04875.x","article-title":"Molecular characterization of erm(B)- and mef(E)-mediated erythromycin-resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010","volume":"110","author":"Li","year":"2011","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0015","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2013Advisory Committee on Immunization Practices, 2010","volume":"59","author":"CDC","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306212528_CIT0016","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/INF.0000000000000849","article-title":"Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia","volume":"34","author":"Desai","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180306212528_CIT0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0018","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199508243330803","article-title":"The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta","volume":"333","author":"Hofmann","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306212528_CIT0019","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-Ninth Edition. CLSI document M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"key\n\t\t\t\t20180306212528_CIT0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/JCM.01919-08","article-title":"PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007","volume":"47","author":"Carvalho","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0021","doi-asserted-by":"crossref","first-page":"e0116254","DOI":"10.1371\/journal.pone.0116254","article-title":"Transcriptional attenuation controls macrolide inducible efflux and resistance in Streptococcus pneumoniae and in other gram-positive bacteria containing mef\/mel(msr(D)) elements","volume":"10","author":"Chancey","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306212528_CIT0022","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306212528_CIT0023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306212528_CIT0024","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180306212528_CIT0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cir326","article-title":"Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States","volume":"53","author":"Rosen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0026","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0027","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/518149","article-title":"Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine","volume":"44","author":"Albrich","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0028","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306212528_CIT0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/mdr.1998.4.325","article-title":"Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States","volume":"4","author":"Corso","year":"1998","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20180306212528_CIT0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/44.1.19","article-title":"A variety of gram-positive bacteria carry mobile mef genes","volume":"44","author":"Luna","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0031","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jac\/43.5.637","article-title":"Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics","volume":"43","author":"Nishijima","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0032","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/AAC.45.5.1595-1598.2001","article-title":"Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa","volume":"45","author":"McGee","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306212528_CIT0033","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/gbe\/evu120","article-title":"Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape","volume":"6","author":"Croucher","year":"2014","journal-title":"Genome Biol Evol"},{"key":"key\n\t\t\t\t20180306212528_CIT0034","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2180-12-12","article-title":"Dominance of multidrug resistant CC271 clones in macrolide-resistant Streptococcus pneumoniae in Arizona","volume":"12","author":"Bowers","year":"2012","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20180306212528_CIT0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0036","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1016\/j.vaccine.2013.10.038","article-title":"Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: the dynamics of PCV13 vaccine uptake","volume":"31","author":"Schuck-Paim","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306212528_CIT0037","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices","volume":"63","author":"Tomczyk","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306212528_CIT0038","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306212528_CIT0039","doi-asserted-by":"crossref","first-page":"e0142892","DOI":"10.1371\/journal.pone.0142892","article-title":"Serotype distribution, antimicrobial susceptibility, and molecular epidemiology of Streptococcus pneumoniae isolated from children in Shanghai, China","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306212528_CIT0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.micinf.2015.02.001","article-title":"Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities","volume":"17","author":"Xiao","year":"2015","journal-title":"Microbes Infect"},{"key":"key\n\t\t\t\t20180306212528_CIT0041","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0042","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306212528_CIT0043","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/6\/990\/24266302\/cix446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:06:47Z","timestamp":1750280807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/6\/990\/3950322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,7,10]]},"published-print":{"date-parts":[[2017,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix446","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,15]]},"published":{"date-parts":[[2017,7,10]]}}}